126 related articles for article (PubMed ID: 6387363)
1. Purification and inactivation of the factor X activator of Russell's viper venom with monoclonal antibodies.
Pukrittayakamee S; Esnouf MP; McMichael AJ
Mol Biol Med; 1983 Jul; 1(1):123-35. PubMed ID: 6387363
[TBL] [Abstract][Full Text] [Related]
2. Immunoaffinity chromatographic purification of Russell's viper venom factor X activator using elution in high concentrations of magnesium chloride.
Durkee KH; Roh BH; Doellgast GJ
Protein Expr Purif; 1993 Oct; 4(5):405-11. PubMed ID: 8251752
[TBL] [Abstract][Full Text] [Related]
3. Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies.
Meenatchisundaram S; Parameswari G; Michael A; Ramalingam S
Int Immunopharmacol; 2008 Aug; 8(8):1067-73. PubMed ID: 18550009
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel pro-coagulant metalloprotease (RVBCMP) possessing alpha-fibrinogenase and tissue haemorrhagic activity from venom of Daboia russelli russelli (Russell's viper): evidence of distinct coagulant and haemorrhagic sites in RVBCMP.
Mukherjee AK
Toxicon; 2008 Apr; 51(5):923-33. PubMed ID: 18249434
[TBL] [Abstract][Full Text] [Related]
5. A competitive radioimmunoassay using a monoclonal antibody to detect the factor X activator of Russell's viper venom.
Pukrittayakamee S; Ratcliffe PJ; McMichael AJ; Warrell DA; Bunnag D
Toxicon; 1987; 25(7):721-9. PubMed ID: 3313812
[TBL] [Abstract][Full Text] [Related]
6. Ability of a small, basic protein isolated from Russell's viper venom (Daboia russelli russelli) to induce renal tubular necrosis in mice.
Mandal S; Bhattacharyya D
Toxicon; 2007 Aug; 50(2):236-50. PubMed ID: 17499831
[TBL] [Abstract][Full Text] [Related]
7. Factor X-activating glycoprotein of Russell's viper venom. Polypeptide composition and characterization of the carbohydrate moieties.
Gowda DC; Jackson CM; Hensley P; Davidson EA
J Biol Chem; 1994 Apr; 269(14):10644-50. PubMed ID: 8144654
[TBL] [Abstract][Full Text] [Related]
8. New insights into the functions and N-glycan structures of factor X activator from Russell's viper venom.
Chen HS; Chen JM; Lin CW; Khoo KH; Tsai IH
FEBS J; 2008 Aug; 275(15):3944-58. PubMed ID: 18616470
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a monoclonal antibody that neutralizes the hyaluronidase activity of Russell's viper venom.
Pukrittayakamee S; Nontprasert A; White NJ; Warrell DA; Bunnag D
Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):231-7. PubMed ID: 2237592
[TBL] [Abstract][Full Text] [Related]
10. Effect of purified Russell's viper venom-factor X activator (RVV-X) on renal hemodynamics, renal functions, and coagulopathy in rats.
Suntravat M; Yusuksawad M; Sereemaspun A; Pérez JC; Nuchprayoon I
Toxicon; 2011 Sep; 58(3):230-8. PubMed ID: 21704055
[TBL] [Abstract][Full Text] [Related]
11. Core sugar residues of the N-linked oligosaccharides of Russell's viper venom factor X-activator maintain functionally active polypeptide structure.
Gowda DC; Jackson CM; Kurzban GP; McPhie P; Davidson EA
Biochemistry; 1996 May; 35(18):5833-7. PubMed ID: 8639544
[TBL] [Abstract][Full Text] [Related]
12. Sodium oleate, arachidonate, and linoleate enhance fibrinogenolysis by Russell's viper venom proteinases and inhibit FXIIIa; a role for phospholipase A
Alangode A; Reick M; Reick M
Toxicon; 2020 Oct; 186():83-93. PubMed ID: 32755649
[TBL] [Abstract][Full Text] [Related]
13. Affinity-purification of fibrinogenase with high proteolytic activity from Agkistrodon halys (Chinese) Venom.
Ma B; Zhang Y; Wu D; Jia J; Xu W; Luo Y
Arch Pharm Res; 2008 Sep; 31(9):1129-36. PubMed ID: 18806955
[TBL] [Abstract][Full Text] [Related]
14. Understanding Russell's viper venom factor V activator's substrate specificity by surface plasmon resonance and in-silico studies.
Yadav PK; Antonyraj CB; Basheer Ahamed SI; Srinivas S
PLoS One; 2017; 12(7):e0181216. PubMed ID: 28732041
[TBL] [Abstract][Full Text] [Related]
15. Russell's viper venom fractions and nephrotoxicity.
Swe TN; Kyaw KM; Win H; Win K; Htwe TT
Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):657-63. PubMed ID: 9561625
[TBL] [Abstract][Full Text] [Related]
16. Effects of Russell's viper venom on mediator production in cultured human umbilical vein endothelial cells.
Thamaree S; Sitprija V; Punyavoravuth V; Akarasereenont P; Puckmanee N; Khow O; Thaworn N
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S197-207. PubMed ID: 11529335
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of a potent hemolytic toxin with phospholipase A2 activity from the venom of Indian Russell's viper.
Chakraborty AK; Hall RH; Ghose AC
Mol Cell Biochem; 2002 Aug; 237(1-2):95-102. PubMed ID: 12236591
[TBL] [Abstract][Full Text] [Related]
18. Coagulation factor X activating enzyme from Russell's viper venom (RVV-X). A novel metalloproteinase with disintegrin (platelet aggregation inhibitor)-like and C-type lectin-like domains.
Takeya H; Nishida S; Miyata T; Kawada S; Saisaka Y; Morita T; Iwanaga S
J Biol Chem; 1992 Jul; 267(20):14109-17. PubMed ID: 1629211
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivities of polyclonal antibodies against lebetase, fibrinolytic enzyme of Levantine viper (Vipera lebetina) venom.
Siigur J; Tõnismägi K; Tu AT; Siigur E
Toxicon; 1996 May; 34(5):608-13. PubMed ID: 8783456
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-linked coagulation assay. IV. Sensitive sandwich enzyme-linked immunosorbent assays using Russell's viper venom factor X activator-antibody conjugates.
Doellgast GJ
Anal Biochem; 1987 Nov; 167(1):97-105. PubMed ID: 3481224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
